Isunakinra

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameIsunakinra
Drug Alias Name艾苏那靳雷Isunakinrum依舒白滞素EBI-005-2EBI-005-1 +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsSolid tumoursDry Eye SyndromesXerophthalmia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSesen Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesBuzzard Pharmaceuticals Ab
Inactive CompaniesEleven Biotherapeutics Inc
Active IndicationsSolid tumoursColorectal Neoplasms
Inactive IndicationsDry Eye SyndromesXerophthalmiaConjunctivitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A